Thomas Sciascia

535 total citations
18 papers, 367 citations indexed

About

Thomas Sciascia is a scholar working on Dermatology, Rheumatology and Physiology. According to data from OpenAlex, Thomas Sciascia has authored 18 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 9 papers in Rheumatology and 9 papers in Physiology. Recurrent topics in Thomas Sciascia's work include Dermatology and Skin Diseases (10 papers), Urticaria and Related Conditions (9 papers) and Asthma and respiratory diseases (9 papers). Thomas Sciascia is often cited by papers focused on Dermatology and Skin Diseases (10 papers), Urticaria and Related Conditions (9 papers) and Asthma and respiratory diseases (9 papers). Thomas Sciascia collaborates with scholars based in United States, Poland and Germany. Thomas Sciascia's co-authors include Howard Hait, Amale Hawi, Kumar Jayant, Vandana Mathur, Jacek C. Szepietowski, Sonja Ständer, Gil Yosipovitch, Jolene Kay Berg, Harry Alcorn and David R. Lynch and has published in prestigious journals such as Journal of the American Academy of Dermatology, Movement Disorders and Scientific American.

In The Last Decade

Thomas Sciascia

17 papers receiving 359 citations

Peers

Thomas Sciascia
Vivian Rismondo United States
Satoko Nakahara Japan
R S Kelleher United States
Kemal Gündüz Türkiye
Sunao Toda Japan
Dominick L. Auci United States
Clarissa Giannini Italy
Mary Lynn Dear United States
Ana C. Londoño United States
William J. Chapin United States
Vivian Rismondo United States
Thomas Sciascia
Citations per year, relative to Thomas Sciascia Thomas Sciascia (= 1×) peers Vivian Rismondo

Countries citing papers authored by Thomas Sciascia

Since Specialization
Citations

This map shows the geographic impact of Thomas Sciascia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Sciascia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Sciascia more than expected).

Fields of papers citing papers by Thomas Sciascia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Sciascia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Sciascia. The network helps show where Thomas Sciascia may publish in the future.

Co-authorship network of co-authors of Thomas Sciascia

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Sciascia. A scholar is included among the top collaborators of Thomas Sciascia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Sciascia. Thomas Sciascia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Birring, Surinder S., Peter V. Dicpinigaitis, Toby M. Maher, et al.. (2025). Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment. Lung. 203(1). 62–62. 1 indexed citations
2.
3.
Korzekwa, Ken, Swati Nagar, David W. Clark, Thomas Sciascia, & Amale Hawi. (2024). A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate. Molecular Pharmaceutics. 21(9). 4510–4523. 4 indexed citations
4.
Riggs, Matthew M., et al.. (2023). A population pharmacokinetic–pharmacodynamic model evaluating efficacy of nalbuphine extended‐release in patients with prurigo nodularis. British Journal of Clinical Pharmacology. 89(7). 2088–2101. 1 indexed citations
5.
Maher, Toby M., Cristina Avram, Simon P. Hart, et al.. (2023). Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis. NEJM Evidence. 2(8). EVIDoa2300083–EVIDoa2300083. 40 indexed citations
6.
Elmariah, Sarina B., Sarah Chisolm, Thomas Sciascia, & Shawn G. Kwatra. (2022). Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications. JAAD International. 7. 156–163. 12 indexed citations
7.
Ständer, Sonja, Elke Weißhaar, Jacek C. Szepietowski, et al.. (2022). Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b/3, Double-Blind, Placebo-Controlled Study. SKIN The Journal of Cutaneous Medicine. 6(6). s103–s103. 2 indexed citations
8.
Kim, Brian, Saadet Inan, Sonja Ständer, et al.. (2022). Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits. Experimental Dermatology. 31(12). 1900–1907. 34 indexed citations
9.
Weißhaar, Elke, Jacek C. Szepietowski, Howard Hait, et al.. (2021). Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phase. Journal of the European Academy of Dermatology and Venereology. 36(3). 453–461. 31 indexed citations
10.
Kim, Brian, Thomas Sciascia, & Gil Yosipovitch. (2021). The Role of Kappa- and Mu-Opioid Receptors in Pruritus. SKIN The Journal of Cutaneous Medicine. 5(1). s31–s31. 1 indexed citations
11.
Ständer, Sonja, Claudia Zeidler, Manuel P. Pereira, et al.. (2021). Worst itch numerical rating scale for prurigo nodularis: a psychometric evaluation. Journal of the European Academy of Dermatology and Venereology. 36(4). 573–581. 6 indexed citations
12.
Weißhaar, Elke, Jacek C. Szepietowski, Thomas Sciascia, Gil Yosipovitch, & Sonja Ständer. (2021). 25853 Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open-label extension phase. Journal of the American Academy of Dermatology. 85(3). AB72–AB72. 3 indexed citations
13.
Mathur, Vandana, et al.. (2017). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus. American Journal of Nephrology. 46(6). 450–458. 71 indexed citations
14.
15.
Lynch, David R., Steven M. Willi, Robert B. Wilson, et al.. (2012). A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial. Movement Disorders. 27(8). 1026–1033. 66 indexed citations
16.
Friedman, Lisa S., Kimberly Schadt, Sean R. Regner, et al.. (2012). Elevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxia. International Journal of Cardiology. 167(4). 1622–1624. 17 indexed citations
17.
Hawi, Amale, Sarah L. Heald, & Thomas Sciascia. (2011). Use of an Adaptive Study Design in Single Ascending‐Dose Pharmacokinetics of A0001 (α‐Tocopherylquinone) in Healthy Male Subjects. The Journal of Clinical Pharmacology. 52(1). 65–77. 9 indexed citations
18.
Sciascia, Thomas, et al.. (1986). The Colors of Things. Scientific American. 255(3). 84–91. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivian Rismondo Breakdown of academic impact, for papers by Satoko Nakahara Breakdown of academic impact, for papers by R S Kelleher Breakdown of academic impact, for papers by Kemal Gündüz Breakdown of academic impact, for papers by Sunao Toda Breakdown of academic impact, for papers by Dominick L. Auci Breakdown of academic impact, for papers by Clarissa Giannini Breakdown of academic impact, for papers by Mary Lynn Dear Breakdown of academic impact, for papers by Ana C. Londoño Breakdown of academic impact, for papers by William J. Chapin
Rankless by CCL
2026